Brooks Automation to Participate in the 13th Annual Virtual CEO Investor Summit 2021 CHELMSFORD, Mass., June 4, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the 13th Annual Virtual CEO Investor Summit being held on June 15, 2021. About the 13th Annual Virtual CEO Summit 2021 The CEO... Read more
Data for investigational CD20xCD3 bispecific antibodies and new combination regimens with Polivy showed enhanced clinical benefits for people with non-Hodgkin lymphoma in early studies Basel, 4 June 2021 ‒ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data on its investigational CD20xCD3 T-cell engaging bispecific antibodies, mosunetuzumab and glofitamab, and its first-in-class anti-CD79b... Read more
CHICAGO (June 3, 2021) – GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes. The Consortium brings... Read more
Design provides comprehensive content and flexible exome options SANTA CLARA, Calif., June 02, 2021 Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture... Read more
Changzhou, China, operations become Avantor’s first single-use production facility in AMEA region; doubles Avantor’s global single-use cleanroom space Adds proprietary technologies to Avantor’s bioprocessing manufacturing capabilities to meet growing global demand for single-use solutions RADNOR, Pa. and SHANGHAI, June 1, 2021 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the... Read more
Company’s 2020 Sustainability Report tracks progress in tackling critical global challenges of water access, affordability and resilience Helping customers reuse 4.3B m3 of water, or more than 1 trillion gallons, equivalent to almost two million Olympic swimming pools Technology kept 1.4B m3 of polluted water from potentially flooding communities and entering waterways Assisted 4.1M underserved... Read more
Unique timsTOF SCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more
Unique timsTOF trueSCP revolutionizes quantitative single cell biology research with unbiased, deep single-cell 4D-Proteomics™ to complement scRNA-seq; breakthrough paper by Mann et al. identifies and quantifies >1,400 proteins in single cells Next-generation timsTOF Pro 2 with unprecedented depth and throughput for unbiased 4D-Proteomics; supports liquid biopsy multiomic biomarker research, integrating genomics with proteomics and epiproteomics;... Read more
SAN DIEGO–(BUSINESS WIRE)–Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and/or developmental disorders (DD) in routine care. The study, run by the Belgian Resolve Rare Diseases group (BeSolveRD), will also assess the health economic impact of WGS... Read more